(Reuters) -Baxter International on Thursday trimmed its forecasts for adjusted annual profit and revenue growth, after missing third-quarter revenue estimates due to persistent impact from hurricane-related disruptions at a key manufacturing unit.

Shares of the medical products maker were down more than 13% in premarket trading following the results.

Despite an uptick in non-essential medical procedures during the quarter, the company now expects adjusted earnings of $2.35 to $2.40 per share, down from its prior view of $2.42 and $2.52 per share.

It lowered its annual sales growth forecast to a range of 4% to 5% from the previous projection of 6% to 7% on a reported basis.

Baxter’s North Cove facility in North Carolina, which supplies 60% of IV fluids and peritoneal dialysis solutions

See Full Page